Participants 15 63 5
breast-cancer prevention in postmenopausal women
Participants 285 324 3
patients with early-stage breast cancer
Participants 475 834 10
eligible postmenopausal women 35 years of age or older had at least one of the following risk factors: 60 years of age or older; Gail 5-year risk score greater than 1.66% (chances in 100 of invasive breast cancer developing within 5 years); prior atypical ductal or lobular hyperplasia or lobular carcinoma in situ; or ductal carcinoma in situ with mastectomy
Participants 933 1088 6
A total of 4560 women for whom the median age was 62.5 years and the median Gail risk score was 2.3% were randomly assigned to either exemestane or placebo
Participants 1934 2038 5
invasive breast cancers in postmenopausal women who were at moderately increased risk for breast cancer.
